Wednesday, Jun 29, 2022
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle

"pfizer"

  • Pfizer launches free online course on antimicrobial resistance for nurses

    Hyderabad: Pfizer India on Monday announced the launch of  ‘Open-AMR’, a free online platform to educate nurses on Antimicrobial Resistance (AMR) in English and other regional languages including Telugu. The Open-AMR initiative is a web-based platform that can be accessed by any nurse anywhere in India for free in seven different languages including English, Hindi, […]
  • Pfizer says Covid shot 80% effective in young kids

    Washington: Pfizer and its German partner BioNTech have said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old at preventing illness during the Omicron wave. The vaccine was found to elicit a strong immune response following a third dose, and was […]
  • ‘Covid 4th wave will start in June-July and last till September’

    Bengaluru: Predictive studies opine that the 4th wave of the Covid-19 will start in June-July and last till September, stated Karnataka Health Minister K. Sudhakar on Tuesday. “Karnataka is prepared to face it,” he added. He said that there is no need to worry as of now. The new XE variant of Covid-19 is prominent […]
  • KTR meets top officials of world’s largest pharma companies

    Hyderabad: Continuing his efforts to get investments into Telangana, Industries Minister KT Rama Rao met senior officials of world’s largest pharma companies, including Pfizer, J&J and GSK in the United States on Friday. The three companies together represent more than 170 billions US dollars in annual revenue and the combined employee strength of these organizations […]
  • Three Hyderabad firms to make generic version of Pfizer’s Covid drug

    Hyderabad: Three pharma companies from Hyderabad have entered into agreement with UN-backed Medicines Patent Pool (MPP), headquartered in Geneva, to manufacture and supply a generic version of Pfizer’s Covid-19 oral treatment Nirmatrelvir. Aurobindo Pharma said it signed a sub-license agreement with MPP. Earlier, MPP signed voluntary licensing agreement with Pfizer for sub-licensing this Covid-19 treatment […]
  • Pfizer, CornoaVac vax linked to heart inflammation risk in adolescents

    Hong Kong: Despite low absolute risk, there is an increased relative risk of carditis — a type of heart inflammation — associated with Covid vaccine developed by US drugmaker Pfizer and China’s CoronaVac, researchers have found. The findings, published in Annals of Internal Medicine, show a significant increased risk in adolescents after the second dose. […]
  • Covid booster dose provides good antibody protection against Omicron: Lancet

    London: A third ‘booster’ dose of Covid-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings. Published as a research letter in The Lancet, researchers including from the Francis Crick Institute and UCLH Biomedical Research, found that antibodies generated in people who had received only two doses of either the […]
  • Pfizer’s Covid pill effective against Omicron variant

    Washington: Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalisations and deaths by about 89 per cent among high-risk adults when taken shortly after […]
  • Pfizer vaccine 40 times less effective against Omicron: South African study

    Johannesburg: Pfizer’s mRNA-based Covid vaccine may be up to 40 times less effective against the new super mutant Omicron variant, a small study led by South African researchers have shown. The emergence of the Omicron variant of SARS-CoV-2 in November in South Africa has raised concerns that, based on the large number of mutations in […]
  • Editorial: End vaccine inequality

    The global fears over the emergence of Omicron, the new and more virulent coronavirus variant, once again highlight an often neglected aspect of the pandemic: Vaccine inequality. The widening gulf between the rich and the poor nations in terms of inoculation coverage makes the fight against the virus less effective. Access to life-saving vaccines makes […]
1 2 3 … 7 »

Latest News

  • Telangana: Lands encroached by Jamuna Hatchiers handed over to farmers in Medak

    14 mins ago
  • Telangana: Two die in a road accident in Manthani

    35 mins ago
  • Monkeypox’ likelihood of becoming pandemic low: Researchers

    44 mins ago
  • India records 14,506 new Covid cases, 30 deaths

    58 mins ago
  • Udaipur horror: K’taka BJP launches online campaign against Cong

    1 hour ago
  • “Bye bye Modi” hoarding at Hyderabad’s Begumpet sends police into a tizzy

    1 hour ago
  • Facebook testing new ways to organise, quickly access Groups

    2 hours ago
  • New research on airborne stability and infectivity of SARS-CoV-2 could help mitigate spread of diseases

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam